We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Biologic Mesh for Hiatal Hernias Appears Safe

By HospiMedica International staff writers
Posted on 19 Jun 2012
A new study reported no major complications associated with use of biologic mesh to repair large hiatal hernias, contrasting other recent studies that have shown an increased risk for morbidity related to prosthetic and biologic meshes in these patients.

Researchers at the University of Washington (Seattle, USA) conducted a study involving 126 patients who had biologic mesh placed at the hiatus and who had been followed for at least one year. More...
Perioperative data were reviewed, and a questionnaire was administered, designed to identify symptoms of gastroesophageal reflux disease (GERD), other symptoms such as dysphagia, and all other operative or endoscopic interventions that occurred after mesh implantation. In addition, postoperative radiologic and endoscopic studies were reviewed to assess signs of complications related to use of mesh.

The researchers were able to contact 73 of the patients, at median follow-up of 45 months. No mesh-related complications were found. The frequency and severity of heartburn, regurgitation, and dysphagia improved significantly compared with preoperative values, and 89% of the patients reported good to excellent results in terms of overall satisfaction. Overall, the rate of dysphagia in the study was 2%, but no case seemed to be directly related to the mesh. No erosions, strictures, or other complications directly related to use of mesh were found. Only one patient required reoperation due to hiatal hernia recurrence with GERD symptoms. The study was published in the May 2012 issue of Surgical Endoscopy.

“Given the potential benefits of biologic mesh, we believe that surgeons who pay careful attention to its placement should feel reassured in the safety of using these meshes during hiatal hernia repair,” concluded lead author Eelco Wassenaar, MD, and colleagues of the department of surgery.

Dr. Wassenaar added that the surgical team used three key strategies that may reduce the risk for complications. The first was the use of a U-shaped, rather than a keyhole configuration, which leaves an open area in the anterior aspect of the esophagus. They also recommended covering the hiatus posterior to the esophagus, taking care to avoid pulling the mesh anteriorly and lifting the esophagus posteriorly to avoid narrowing of the esophagus. A third suggestion was to leave a small space between the edge of the mesh and the esophageal wall to avoid excessive contact of the mesh with the esophagus, which could lead to fibrosis and scarring, and potentially esophageal stricture.

Related Links:

University of Washington



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.